136 related articles for article (PubMed ID: 22770847)
21. Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells.
Ghazizadeh Z; Rassouli H; Fonoudi H; Alikhani M; Talkhabi M; Darbandi-Azar A; Chen S; Baharvand H; Aghdami N; Salekdeh GH
Mol Biotechnol; 2017 Jun; 59(6):207-220. PubMed ID: 28509990
[TBL] [Abstract][Full Text] [Related]
22. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.
Chen JX; Krane M; Deutsch MA; Wang L; Rav-Acha M; Gregoire S; Engels MC; Rajarajan K; Karra R; Abel ED; Wu JC; Milan D; Wu SM
Circ Res; 2012 Jun; 111(1):50-5. PubMed ID: 22581928
[TBL] [Abstract][Full Text] [Related]
23. Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.
Mohamed TM; Stone NR; Berry EC; Radzinsky E; Huang Y; Pratt K; Ang YS; Yu P; Wang H; Tang S; Magnitsky S; Ding S; Ivey KN; Srivastava D
Circulation; 2017 Mar; 135(10):978-995. PubMed ID: 27834668
[TBL] [Abstract][Full Text] [Related]
24. Two-step generation of induced pluripotent stem cells from mouse fibroblasts using Id3 and Oct4.
Moon JH; Heo JS; Kwon S; Kim J; Hwang J; Kang PJ; Kim A; Kim HO; Whang KY; Yoon BS; You S
J Mol Cell Biol; 2012 Feb; 4(1):59-62. PubMed ID: 22131360
[No Abstract] [Full Text] [Related]
25. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
[TBL] [Abstract][Full Text] [Related]
26. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
Meissner A; Wernig M; Jaenisch R
Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
[TBL] [Abstract][Full Text] [Related]
27. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
Cheng D; Lei L; Lu Z; Li Z; Wang H
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
[TBL] [Abstract][Full Text] [Related]
28. Direct Cardiac Reprogramming: A Novel Approach for Heart Regeneration.
Tani H; Sadahiro T; Ieda M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30189626
[TBL] [Abstract][Full Text] [Related]
29. "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors.
Mathison M; Singh VP; Gersch RP; Ramirez MO; Cooney A; Kaminsky SM; Chiuchiolo MJ; Nasser A; Yang J; Crystal RG; Rosengart TK
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1656-1664.e2. PubMed ID: 24755332
[TBL] [Abstract][Full Text] [Related]
30. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
Desponts C; Ding S
Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
[TBL] [Abstract][Full Text] [Related]
31. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
32. Induced cardiomyocyte maturation: Cardiac transcription factors are necessary but not sufficient.
Dal-Pra S; Hodgkinson CP; Dzau VJ
PLoS One; 2019; 14(10):e0223842. PubMed ID: 31622977
[TBL] [Abstract][Full Text] [Related]
33. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
[TBL] [Abstract][Full Text] [Related]
34. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
[TBL] [Abstract][Full Text] [Related]
35. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
[TBL] [Abstract][Full Text] [Related]
36. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
Qi H; Pei D
Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
[No Abstract] [Full Text] [Related]
37. An emerging strategy of gene therapy for cardiac disease.
Yoshida Y; Yamanaka S
Circ Res; 2012 Oct; 111(9):1108-10. PubMed ID: 23065338
[No Abstract] [Full Text] [Related]
38. From fibroblast cells to cardiomyocytes: direct lineage reprogramming.
Yang L
Stem Cell Res Ther; 2011 Jan; 2(1):1. PubMed ID: 21241459
[TBL] [Abstract][Full Text] [Related]
39. Induced pluripotency with endogenous and inducible genes.
Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
[TBL] [Abstract][Full Text] [Related]
40. Induced pluripotent stem (iPS) cell research overview.
Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
